🇺🇸 2-MERCAPTOETHANESULFONIC ACID in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Urinary Tract Infection — 2 reports (18.18%)
  2. Back Pain — 1 report (9.09%)
  3. Disease Recurrence — 1 report (9.09%)
  4. Hepatotoxicity — 1 report (9.09%)
  5. Infection Reactivation — 1 report (9.09%)
  6. Neutropenia — 1 report (9.09%)
  7. Pneumocystis Jiroveci Pneumonia — 1 report (9.09%)
  8. Streptococcal Sepsis — 1 report (9.09%)
  9. Temporal Arteritis — 1 report (9.09%)
  10. Treatment Failure — 1 report (9.09%)

Source database →

2-MERCAPTOETHANESULFONIC ACID in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 2-MERCAPTOETHANESULFONIC ACID approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 2-MERCAPTOETHANESULFONIC ACID in United States?

Marketing authorisation holder not available in our data.